LABOPHAR Ltd is a private Rwandan company that has been
manufacturing pharmaceutical products since 1983 with a
mission to avail high quality affordable medicines in Rwanda
and Africa. LABOPHAR was acquired from the Government of
Rwanda by Depot Pharmaceutique et Materiel Medical
Kalisimbi (DPMMK) Ltd in April 2024.
Depot Pharmaceutique et Materiel Medical Kalisimbi (DPMMK) is
an experienced Rwandan owned company. DPMMK Ltd
produces and supplies medical oxygen and Nitrogen, supplies
pharmaceutical products and equipment to different health
facilities in Rwanda and in the region.
DPMMK manage the landfill of Nduba and provide the
treatment of hazardous waste services to public and private
institutions in Rwanda. In 2019, DPMMK Ltd purchased
Mageragere industrial incinerator from the Government of
Rwanda.
LABOPHAR is undertaking a strategic expansion by establishing
a new manufacturing facility for intravenous (IV) fluids, in bags,
Syrups and Ointments. The facility will meet current Good
Manufacturing Practices (cGMP) and global regulatory
requirements.
Company Details
- Address
- Kigali, Rw
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- to public and private.
- HQ
- Kigali
Labophar Questions
Labophar's LinkedIn profile is https://rw.linkedin.com/company/labophar-ltd
Labophar's industry is
Pharmaceutical Manufacturing
Labophar's top competitors are
Menarini Stemline,
Naari Pharma Pvt Ltd.,
Reworks Solutions,
Apex Biotech Inc,
Leica Biosystems,
Takeda Oncology,
Tigermed,
Boston Biopharma,
Roche Diagnóstica Brasil,
Rwanda Biomedical Centre.
Labophar's categories are Pharmaceutical Manufacturing
